Non-steroidal anti-inflammatory drugs and cardiovascular risk.
Allwood
Brian
B
Blockman
Marc
M
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D002318:Cardiovascular Diseases / Q000201:enzymology / Q000453:epidemiology*; D051545:Cyclooxygenase 1 / Q000187:drug effects / Q000378:metabolism; D051546:Cyclooxygenase 2 / Q000187:drug effects / Q000378:metabolism; D016861:Cyclooxygenase Inhibitors / Q000627:therapeutic use; D004347:Drug Interactions; D006801:Humans; D009017:Morbidity; D011379:Prognosis; D012307:Risk Factors; D015996:Survival Rate / Q000639:trends
D000894:Anti-Inflammatory Agents, Non-Steroidal; D016861:Cyclooxygenase Inhibitors; D051545:Cyclooxygenase 1; D051546:Cyclooxygenase 2